Somatostatin, somatostatin receptors, and pancreatic cancer
- PMID: 15706439
- DOI: 10.1007/s00268-004-7814-5
Somatostatin, somatostatin receptors, and pancreatic cancer
Abstract
Somatostatin may play an important role in the regulation of cancer growth including pancreatic cancer by interaction with somatostatin receptors (SSTRs) on the cell surface. Five SSTRs were cloned, and the function of these SSTRs is addressed in this review. SSTR-2, SSTR-5, and SSTR-1 are thought to play major roles in inhibiting pancreatic cancer growth both in vitro and in vivo. SSTR-3 may be involved in mediating apoptosis, but the role of SSTR-4 is not clear. In most pancreatic cancers, functional SSTRs are absent. Reintroduction of SSTR genes has been shown to inhibit pancreatic cancer growth in cell cultures and animal models.
Similar articles
-
Transfection of SSTR-1 and SSTR-2 inhibits Panc-1 cell proliferation and renders Panc-1 cells responsive to somatostatin analogue.J Am Coll Surg. 2005 Oct;201(4):571-8. doi: 10.1016/j.jamcollsurg.2005.06.089. J Am Coll Surg. 2005. PMID: 16183496
-
Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR.J Surg Res. 2004 Jun 15;119(2):130-7. doi: 10.1016/j.jss.2004.03.006. J Surg Res. 2004. PMID: 15145694
-
Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers.Clin Cancer Res. 2001 Sep;7(9):2854-61. Clin Cancer Res. 2001. PMID: 11555603
-
Biology of somatostatin in breast cancer.Mol Cell Endocrinol. 2008 May 14;286(1-2):251-61. doi: 10.1016/j.mce.2008.01.006. Epub 2008 Jan 20. Mol Cell Endocrinol. 2008. PMID: 18308465 Review.
-
Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.J Endocrinol Invest. 2005;28(11 Suppl International):111-7. J Endocrinol Invest. 2005. PMID: 16625859 Review.
Cited by
-
The role of chemotherapy and/or octreotide in patients with metastatic gastroenteropancreatic and hepatobiliary neuroendocrine carcinoma.J Gastrointest Oncol. 2014 Dec;5(6):457-62. doi: 10.3978/j.issn.2078-6891.2014.075. J Gastrointest Oncol. 2014. PMID: 25436125 Free PMC article.
-
Current trends and future prospects of drug repositioning in gastrointestinal oncology.Front Pharmacol. 2024 Jan 4;14:1329244. doi: 10.3389/fphar.2023.1329244. eCollection 2023. Front Pharmacol. 2024. PMID: 38239190 Free PMC article. Review.
-
Comparative Transcriptome Analyses of Leg Muscle during Early Growth between Geese (Anser cygnoides) Breeds Differing in Body Size Characteristics.Genes (Basel). 2023 May 7;14(5):1048. doi: 10.3390/genes14051048. Genes (Basel). 2023. PMID: 37239409 Free PMC article.
-
Somatostatin Receptor 2: A Potential Predictive Biomarker for Immune Checkpoint Inhibitor Treatment.Pathol Oncol Res. 2022 Feb 21;28:1610196. doi: 10.3389/pore.2022.1610196. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35264912 Free PMC article.
-
A signature of 18 immune-related gene pairs to predict the prognosis of pancreatic cancer patients.Immun Inflamm Dis. 2020 Dec;8(4):713-726. doi: 10.1002/iid3.363. Epub 2020 Oct 31. Immun Inflamm Dis. 2020. PMID: 33128857 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical